Experienced in Leukemia
Experienced in Leukemia
201 Lyons Ave, Valerie Fund Childrens Center, 
Newark, NJ 

Overview

Peri Kamalakar is a Pediatric Hematologist Oncology provider in Newark, New Jersey. Dr. Kamalakar is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Adult Soft Tissue Sarcoma, and Immune Thrombocytopenic Purpura (ITP).

His clinical research consists of co-authoring 1 peer reviewed article and participating in 24 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 9 clinical trials in the study of Leukemia.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

201 Lyons Ave, Valerie Fund Childrens Center, Newark, NJ 07112

Additional Areas of Focus

Dr. Kamalakar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


24 Clinical Trials

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 22 Less Clinical Trials
Similar Doctors
Elite in Leukemia
Pediatric Hematology Oncology
Elite in Leukemia
Pediatric Hematology Oncology

New York University

550 1st Ave, 
New York, NY 
 (12.7 miles away)
Languages Spoken:
English

Elizabeth Raetz is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Raetz is rated as a Distinguished provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Distinguished in Leukemia
Pediatric Hematology Oncology
Distinguished in Leukemia
Pediatric Hematology Oncology
195 Little Albany St, 
New Brunswick, NJ 
 (19.2 miles away)
Languages Spoken:
English

Peter Cole is a Pediatric Hematologist Oncology provider in New Brunswick, New Jersey. Dr. Cole is rated as a Distinguished provider by MediFind in the treatment of Leukemia. His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Classical Hodgkin Lymphoma.

Distinguished in Leukemia
Pediatric Hematology Oncology
Distinguished in Leukemia
Pediatric Hematology Oncology
1275 York Ave # H-1407, 
New York, NY 
 (14.0 miles away)
Languages Spoken:
English

Maria Sulis is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Sulis is rated as an Advanced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, and L1 Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kamalakar's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile